Article info

Download PDFPDF
Systematic review
Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications

Authors

  1. Correspondence to: Dr Maria T DeSancho
    1305 York Avenue, 7th floor, New York, NY 10021, USA; mtd2002{at}med.cornell.edu
View Full Text

Citation

DeSancho MT, Pastores SM
Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications

Publication history

  • First published June 27, 2012.
Online issue publication 
January 17, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.